OpenAI has launched GPT-Rosalind, a specialized AI model for life sciences designed to speed up drug discovery and biological research. The model outperforms previous iterations in bioinformatics benchmarks and has demonstrated expert-level accuracy in RNA sequence prediction. Currently available through a trusted access program.